These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10895858)

  • 1. Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function.
    Novak EJ; Ortqvist E; Nord E; Edwall L; Hampe CS; Bekris L; Persson BE; Lernmark A
    Diabetes Care; 2000 Jul; 23(7):1019-21. PubMed ID: 10895858
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 3. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
    Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between GAD antibody and residual beta-cell function in children after overt onset of IDDM.
    Yokota I; Shirakawa N; Shima K; Matsuda J; Naito E; Ito M; Kuroda Y
    Diabetes Care; 1996 Jan; 19(1):74-5. PubMed ID: 8720540
    [No Abstract]   [Full Text] [Related]  

  • 6. Do GAD antibodies at IDDM onset predict the clinical course of diabetes in children?
    Kordonouri O; Danne T; Weber B
    Diabetes Care; 1996 Aug; 19(8):901-2. PubMed ID: 8842617
    [No Abstract]   [Full Text] [Related]  

  • 7. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
    Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
    Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual B-cell function and glycaemic control in diabetic pregnancy.
    Pirttiaho HI; Hartikainen-Sorri AL; Kaila JM; Puukka R
    Horm Metab Res; 1986 Apr; 18(4):250-2. PubMed ID: 3519412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry.
    De Block CE; De Leeuw IH; Rooman RP; Winnock F; Du Caju MV; Van Gaal LF
    Diabet Med; 2000 Aug; 17(8):618-22. PubMed ID: 11073185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.
    Redondo MJ; Rodriguez LM; Escalante M; Smith EO; Balasubramanyam A; Haymond MW
    Pediatr Diabetes; 2013 Aug; 14(5):333-40. PubMed ID: 23458188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study.
    Allen HF; Klingensmith GJ; Jensen P; Simoes E; Hayward A; Chase HP
    Diabetes Care; 1999 Oct; 22(10):1703-7. PubMed ID: 10526739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid peroxidase antibodies in pregnant women with type 1 diabetes: impact on thyroid function, metabolic control and pregnancy outcome.
    Vestgaard M; Nielsen LR; Rasmussen AK; Damm P; Mathiesen ER
    Acta Obstet Gynecol Scand; 2008; 87(12):1336-42. PubMed ID: 18972269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting insulin dependent diabetes mellitus.
    Misra A
    Natl Med J India; 1995; 8(2):69-70. PubMed ID: 7735065
    [No Abstract]   [Full Text] [Related]  

  • 16. Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes.
    Toft-Nielsen MB; Madsbad S; Holst JJ
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3853-60. PubMed ID: 11502823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
    Chaillous L; Lefèvre H; Thivolet C; Boitard C; Lahlou N; Atlan-Gepner C; Bouhanick B; Mogenet A; Nicolino M; Carel JC; Lecomte P; Maréchaud R; Bougnères P; Charbonnel B; Saï P
    Lancet; 2000 Aug; 356(9229):545-9. PubMed ID: 10950231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk.
    Hämäläinen AM; Ronkainen MS; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4249-53. PubMed ID: 11095462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
    Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate decarboxylase antibody levels predict rate of beta-cell decline in adult-onset diabetes.
    Gottsäter A; Landin-Olsson M; Lernmark A; Fernlund P; Sundkvist G; Hagopian WA
    Diabetes Res Clin Pract; 1995 Feb; 27(2):133-40. PubMed ID: 7607051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.